These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1769933)

  • 1. Cefaclor in the treatment of chronic bronchitis.
    J Antimicrob Chemother; 1991 Jul; 28(1):141-4. PubMed ID: 1769933
    [No Abstract]   [Full Text] [Related]  

  • 2. Cefaclor therapy in acute exacerbations of chronic bronchitis.
    Wernstedt L; Berntsson E; Thiringer G
    Postgrad Med J; 1979; 55 Suppl 4():56-8. PubMed ID: 548943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute bronchitis and pneumonia with cefaclor.
    Mattson K; Renkonen OV; Laitinen L; Nikander-Hurme R
    Postgrad Med J; 1979; 55 Suppl 4():59-61. PubMed ID: 398482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral cefaclor for treatment of bronchitis--a comparative double-blind study versus amoxycillin.
    Beumer HM; Veldkamp J
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):113-7. PubMed ID: 7068283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute bacterial bronchitis and pneumonia with cefaclor.
    Mogabgab WJ; Pollock B; Beville RB; Gentry LO; Jemsek JG
    Postgrad Med J; 1979; 55 Suppl 4():62-6. PubMed ID: 44908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefaclor in the treatment of chronic bronchitis.
    Maesen FP; Geraedts WH; Davies BI
    J Antimicrob Chemother; 1990 Sep; 26(3):456-8. PubMed ID: 2228836
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospective randomized study comparing the efficacy and safety of ciprofloxacin with cefaclor in the treatment of patients with purulent bronchitis.
    Quenzer RW; Davis RL; Neidhart MM
    Diagn Microbiol Infect Dis; 1990; 13(2):143-8. PubMed ID: 2196149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loracarbef (LY163892) versus cefaclor in the treatment of acute bacterial bronchitis.
    Dere WH; Farlow D; Therasse DG; Ruoff GE
    Clin Ther; 1992; 14(1):41-53. PubMed ID: 1576625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of cefaclor in the treatment of the acute exacerbation chronic bronchitis].
    Giura R; Roccamo B; Paddeu A; Donghi M; Lanati G; Scardaccione M
    G Ital Chemioter; 1983; 30(2-3):141-3. PubMed ID: 6677545
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of bronchitis with cefaclor (Panoral) (author's transl)].
    Kersten W; Brade W
    MMW Munch Med Wochenschr; 1979 Feb; 121(7):247-50. PubMed ID: 33333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefaclor v amoxycillin in acute exacerbations of chronic bronchitis.
    Ellis-Pegler RB; West SR
    N Z Med J; 1982 Mar; 95(704):201-2. PubMed ID: 7045746
    [No Abstract]   [Full Text] [Related]  

  • 12. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A; Longest KA; Senetar JE; Dere WH
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis.
    Smialowicz CR
    Clin Ther; 1982; 5(2):113-9. PubMed ID: 7159894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
    Grossman RF
    Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Tanimoto H; Nakamori Y
    Jpn J Antibiot; 1988 Sep; 41(9):1319-24. PubMed ID: 3241331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
    Hurst DJ
    Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationship between the pharmacokinetics and pharmacodynamics of cefaclor advanced formulation in patients with acute exacerbation of chronic bronchitis.
    Cazzola M; Di Perna F; Boveri B; Di Marco F; Diamare F; Centanni S
    J Chemother; 2000 Jun; 12(3):216-22. PubMed ID: 10877516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
    Hiraga Y; Omichi M; Sasaoka S
    Jpn J Antibiot; 1988 Sep; 41(9):1304-8. PubMed ID: 3241328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
    Fong IW; Laforge J; Dubois J; Small D; Grossman R; Zakhari R
    Clin Invest Med; 1995 Apr; 18(2):131-8. PubMed ID: 7788958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftibuten versus cefaclor for the treatment of bronchitis.
    Chirurgi VA; Edelstein H; Oster SE; Karp R; Cassano KB; Aiken S; Krumpe P; McCabe RE
    J Antimicrob Chemother; 1991 Oct; 28(4):577-80. PubMed ID: 1761452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.